Skip to main content
Download PDF
  • Research Article
  • Published:

High intracellular Zn2+ ions modulate the VHR, ZAP-70 and ERK activities of LNCaP prostate cancer cells

Cellular & Molecular Biology Letters volume 13, pages 375–390 (2008)Cite this article

Abstract

Malignant prostate tissues have markedly reduced zinc (Zn2+) contents in comparison to non-malignant tissues. In this study, we restored a high intracellular Zn2+ level to LNCaP prostate cancer cells by culturing the cells in a growth medium supplemented with a supraphysiological concentration of Zn2+ (10 μg/ml) over 5 weeks. The intracellular Zn2+ level increased in the Zn2+-treated cells, and there was a marked increase in the presence of zincosomes, a Zn2+-specific intracellular organelle. The proliferation rate of the Zn2+-treated cells was markedly reduced. There was also a significant increase (36.6% ± 6.4%) in the total tyrosine phosphorylated proteins. Vaccinia H1-related (VHR) phosphatase, zeta chain-associated protein-70 (ZAP-70) kinase and phosphorylated extracellular signal-regulated protein kinase 1 and 2 (p-ERK 1 and 2) were also present in higher abundance. Treatment with TPEN, which chelates Zn2+, reduced the abundance of VHR phosphatase and ZAP-70 kinase, but increased the abundance of p-ERK 1. However, the TPEN treatment restored the Zn2+-treated LNCaP cell proliferation to a rate comparable to that of the non Zn2+-treated cells. These results highlight the importance of a high intracellular Zn2+ content and the VHR/ZAP-70-associated pathways in the modulation of LNCaP prostate cancer cell growth.

Abbreviations

ERK:

extracellular signal-regulated protein kinase

KAP:

kinase-associated phosphatase

PTK:

protein tyrosine kinase

PTP:

protein tyrosine phosphatase

PTP1B:

protein tyrosine phosphatase 1B

PTP1C/SHP-1:

protein tyrosine phosphatase 1C

TPEN:

N,N,N′,N′-tetrakis(2-pyridylmethyl)ethylenediamine

VHR:

vaccinia H1-related

ZAP-70:

zeta chain-associated protein-70

References

  1. Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J. and Thun, M.J. Cancer statistics, 2007. CA. Cancer J. Clin. 57 (2007) 43–66.

    Article  PubMed  Google Scholar 

  2. Deutsch, E., Maggiorella, L., Eschwege, P., Bourhis, J., Soria, J.C. and Abdulkarim, B. Environmental, genetic, and molecular features of prostate cancer. Lancet Oncol. 5 (2004) 303–313.

    Article  PubMed  CAS  Google Scholar 

  3. Zaichick, VYe., Sviridova, T.V. and Zaichick, S.V. Zinc in the human prostate gland: normal, hyperplastic and cancerous. Int. Urol. Nephrol. 29 (1997) 565–574.

    Article  PubMed  Google Scholar 

  4. Feng, P., Li, T.L., Guan, Z.X., Franklin, R.B. and Costello, L.C. Direct effect of zinc on mitochondrial apoptogenesis in prostate cells. Prostate 52 (2002) 311–318.

    Article  PubMed  CAS  Google Scholar 

  5. Feng, P., Liang, J.Y., Li, T.L., Guan, Z.X., Zou, J., Franklin, R. and Costello, L.C. Zinc induces mitochondria apoptogenesis in prostate cells. Mol. Urol. 4 (2000) 31–36.

    PubMed  CAS  Google Scholar 

  6. Uzzo, R.G., Crispen, P.L., Golovine, K., Makhov, P., Horwitz, E.M. and Kolenko, V.M. Diverse effects of zinc on NF-κB and AP-1 transcription factors: implications for prostate cancer progression. Carcinogenesis 27 (2006) 1980–1990.

    Article  PubMed  CAS  Google Scholar 

  7. Ishii, K., Usui, S., Sugimura, Y., Yamamoto, H., Yoshikawa, K. and Hirano, K. Inhibition of aminopeptidase N (AP-N) and urokinase-type plasminogen activator (uPA) by zinc suppresses the invasion activity in human urological cancer cells. Biol. Pharm. Bull. 24 (2001) 226–230.

    Article  PubMed  CAS  Google Scholar 

  8. Nemoto, K., Kondo, Y., Himeno, S., Suzuki, Y., Hara, S., Akimoto, M. and Imura, N. Modulation of telomerase activity by zinc in human prostatic and renal cancer cells. Biochem. Pharmacol. 59 (2000) 401–405.

    Article  PubMed  CAS  Google Scholar 

  9. Boissier, S., Ferreras, M., Peyruchaud, O., Magnetto, S., Ebetino, F.H., Colombel, M., Delmas, P., Delaisse, J.M. and Clezardin, P. Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases. Cancer Res. 60 (2000) 2949–2954.

    PubMed  CAS  Google Scholar 

  10. Beyersmann, D. and Haase, H. Functions of zinc in signaling, proliferation and differentiation of mammalian cells. BioMetals 14 (2001) 331–341.

    Article  PubMed  CAS  Google Scholar 

  11. Samet, J.M., Silbajoris, R., Wu, W. and Graves, L.M. Tyrosine phosphatases as targets in metal-induced signaling in human airway epithelial cells. Am. J. Respir. Cell. Mol. Biol. 21 (1999) 357–364.

    PubMed  CAS  Google Scholar 

  12. Haase, H. and Maret, W. Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/insulin-like growth factor-1 signaling. Exp. Cell Res. 291 (2003) 289–298.

    Article  PubMed  CAS  Google Scholar 

  13. Kim, J.H., Cho, H., Ryu, S.E. and Choi, M.U. Effects of metal ions on the activity of protein tyrosine phosphatase VHR: highly potent and reversible oxidative inactivation by Cu2+ ion. Arch. Biochem. Biophys. 382 (2000) 72–80.

    Article  PubMed  CAS  Google Scholar 

  14. Brautigan, D.L., Bornstein, P. and Gallis, B. Phosphotyrosyl-protein phosphatase. Specific inhibition by Zn. J. Biol. Chem. 256 (1981) 6519–6522.

    PubMed  CAS  Google Scholar 

  15. Hansson, A. Extracellular zinc ions induces mitogen-activated protein kinase activity and protein tyrosine phosphorylation in bombesin-sensitive Swiss 3T3 fibroblasts. Arch. Biochem. Biophys. 328 (1996) 233–238.

    Article  PubMed  CAS  Google Scholar 

  16. Huang, S., Maher, V.M. and McCormick, J. Involvement of intermediary metabolites in the pathway of extracellular Ca2+-induced mitogen-activated protein kinase activation in human fibroblasts. Cell Signal 11 (1999) 263–274.

    Article  PubMed  CAS  Google Scholar 

  17. Wu, W, Graves, L.M., Jaspers, I., Devlin, R.B., Reed, W. and Samet, J.M. Activation of the EGF receptor signaling pathway in human airway epithelial cells exposed to metals. Am. J. Physiol. 277 (1999) L924–L931.

    PubMed  CAS  Google Scholar 

  18. Samet, J.M., Graves, L.M., Quay, J., Dailey, L.A., Devlin, R.B., Ghio, A.J., Wu, W., Bromberg, P.A. and Reed, W. Activation of MAPKs in human bronchial epithelial cells exposed to metals. Am. J. Physiol. 275 (1998) L551–L558.

    PubMed  CAS  Google Scholar 

  19. Park, J.A. and Koh, J.Y. Induction of an immediate early gene egr-1 by zinc though extracellular signal-regulated kinase activation in cortical culture: its role in zinc-induced neuronal death. J. Neurochem. 73 (1999) 450–456.

    Article  PubMed  CAS  Google Scholar 

  20. Makino, T., Saito, M., Horiguchi, D. and Kina, K. A highly sensitive colorimetric determination of serum zinc using water-soluble pyridylazo dye. Clin. Chim. Acta. 120 (1982) 127–135.

    Article  PubMed  CAS  Google Scholar 

  21. Huang, L., Kirschke, C.P. and Zhang, Y. Decreased intracellular zinc in human tumorigenic prostate epithelial cells: a possible role in prostate cancer progression. Cancer Cell Int. 6 (2006) 10, DOI: 10.1186/1475-2867-6-10.

    Article  PubMed  CAS  Google Scholar 

  22. Costello, L.C., Liu, Y., Zou, J. and Franklin, R.B. Evidence for a zinc uptake transporter in human prostate cancer cells which is regulated by prolactin and testosterone. J. Biol. Chem. 274 (1999) 17499–17504.

    Article  PubMed  CAS  Google Scholar 

  23. Franklin, R.B., Ma, J., Zou, J., Guan, Z., Kukoyi, B.I., Feng, P. and Costello, L.C. Human ZIP1 is a major zinc uptake transporter for the accumulation of zinc in prostate cells. J. Inorg. Biochem. 96 (2003) 435–442.

    Article  PubMed  CAS  Google Scholar 

  24. Feng, P., Li, T.L., Guan, Z.X., Franklin, R.B. and Costello, L.C. Effect of zinc on prostatic tumorigenicity in nude mice. Ann. N.Y. Acad. Sci. 1010 (2003) 316–320.

    Article  PubMed  CAS  Google Scholar 

  25. Gioeli, D., Mandell, J.W., Petroni, G.R., Frierson, H.F. Jr. and Weber, M.J. Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res. 59 (1999) 279–284.

    PubMed  CAS  Google Scholar 

  26. Ross, J.S., Kallakury, B.V., Sheehan, C.E., Fisher, H.A., Kaufman, R.P. Jr., Kaur, P., Gray, K. and Stringer, B. Expression of nuclear factor-κB and IκBa proteins in prostatic adenocarcinomas: correlation of nuclear factor-κB immunoreactivity with disease recurrence. Clin. Cancer Res. 10 (2004) 2466–2472.

    Article  PubMed  CAS  Google Scholar 

  27. Mulholland, D.J., Dedhar, S., Wu, H. and Nelson, C.C. PTEN and GSK3β: key regulators of progression to androgen-independent prostate cancer. Oncogene 25 (2006) 329–337.

    Article  PubMed  CAS  Google Scholar 

  28. Park, K.S., Lee, N.G., Lee, K.H., Seo, J.T. and Choi, K.Y. The ERK pathway involves positive and negative regulations of HT-29 colorectal cancer cell growth by extracellular zinc. Am. J. Physiol. Gastrointest. Liver Physiol. 285 (2003) G1181–G1188.

    PubMed  CAS  Google Scholar 

  29. Klein, C., Creach, K., Irintcheva, V., Hughes, K.J., Blackwell, P.L., Corbett, J.A., and Baldassare, J.J. Zinc induces ERK-dependent cell death through a specific Ras isoform. Apoptosis 11 (2006) 1933–1944.

    Article  PubMed  CAS  Google Scholar 

  30. Alonso, A., Rahmouni, S., Williams, S., van Stipdonk, M., Jaroszewski, L., Godzik, A., Abraham, R.T., Schoenberger, S.P. and Mustelin, T. Tyrosine phosphorylation of VHR phosphatase by ZAP-70. Nat. Immunol. 4 (2003) 44–48.

    Article  PubMed  CAS  Google Scholar 

  31. Todd, J.L., Tanner, K.G. and Denu, J.M. Extracellular regulated kinases (ERK) 1 and ERK2 are authentic substrates for the dual-specificity proteintyrosine phosphatase VHR, a novel role in down-regulating the ERK pathway. J. Biol. Chem. 274 (1999) 13271–13280.

    Article  PubMed  CAS  Google Scholar 

  32. Rahmouni, S., Cerignoli, F., Alonso, A., Tsutji, T., Henkens, R., Zhu, C., Louis-dit-Sully, C., Moutschen, M., Jiang, W. and Mustelin, T. Loss of the VHR dual-specific phosphatase causes cell-cycle arrest and senescence. Nat. Cell Biol. 8 (2006) 524–531.

    Article  PubMed  CAS  Google Scholar 

  33. Griffith, C.E., Zhang, W. and Wange, R.L. ZAP-70-dependent and-independent activation of Erk in Jurkat T cells. Differences in signaling induced by H2O2 and Cd3 cross-linking. J. Biol. Chem. 273 (1998) 10771–10776.

    Article  PubMed  CAS  Google Scholar 

  34. Pumiglia, K.M. and Decker, S.J. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. USA 94 (1997) 448–452.

    Article  PubMed  CAS  Google Scholar 

  35. Stanciu, M., Wang, Y., Kentor, R., Burke, N., Watkins, S., Kress, G., Reynolds, I., Klann, E., Angiolieri, M.R., Johnson, J.W. and DeFranco, D.B. Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J. Biol. Chem. 275 (2000) 12200–12206.

    Article  PubMed  CAS  Google Scholar 

  36. Goulet, A.C., Chigbrow, M., Frisk, P. and Nelson, M.A. Selenomethionine induces sustained ERK phosphorylation leading to cell-cycle arrest in human colon cancer cells. Carcinogenesis 26 (2005) 109–117.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Microbiology, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia

    Pooi-Fong Wong & Sazaly Abubakar

Authors
  1. Pooi-Fong Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sazaly Abubakar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sazaly Abubakar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wong, PF., Abubakar, S. High intracellular Zn2+ ions modulate the VHR, ZAP-70 and ERK activities of LNCaP prostate cancer cells. Cell Mol Biol Lett 13, 375–390 (2008). https://doi.org/10.2478/s11658-008-0009-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2478/s11658-008-0009-6

Keywords

Cellular & Molecular Biology Letters

ISSN: 1689-1392

Contact us